SLS
SELLAS Life Sciences GroupDNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-21
Current thesis
The core upside case is a binary but potentially large REGAL inflection: management says final analysis follows the 80th event and a positive result could support a BLA path, while SLS009 adds a second AML-focused program with first-line expansion already underway [#8-K-2026-03-19][#10-K-2026-03-19].
Posture
Defensive
Lead driver
Momentum
What changed
Momentum remains the lead driver in the composite, 7D delta -0.1.
What can break
Despite cash of $71.8 million at December 31, 2025 plus $42.6 million of subsequent warrant proceeds, SELLAS still notes it may pursue additional capital or partnerships later [#10-K-2026-03-19].
Momentum
100
Value
41
Sentiment
0
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $5.40 · Bull $7.50 · Bear $2.80
Data freshness
Prices
As of 2026-07-21
Fundamentals
As of 2026-07-20 • Vendor: Data Vendor v1
Scores
As of 2026-07-21 • Model: HYBRID_IC_RP
AI Memo
As of 2026-04-15 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-07-21
Investment thesis
As of 2026-07-21
Supporting evidence
What
Grade D · Defensive
Confidence Medium · Net Neutral
Target $27.50
Why
Momentum100 · Δ7d -0.1
Value41 · Δ7d +0.1
Sentiment0 · Δ7d 0.0
So what
Weak posture (Net Neutral). Prioritize risk control and patience.
Lead driver: Momentum · See technicals
Momentum
100
26% active weight
Current posture
7d trendFlat
Δ7d
-0.1
Δ21d
+1.3
Value
41
39% active weight
Current posture
7d trendFlat
Δ7d
+0.1
Δ21d
-0.0
Sentiment
0
34% active weight
Current posture
7d trendFlat
Δ7d
0.0
Δ21d
0.0
Why this grade
Composite grade D. Momentum 99.7 / Value 41.1 / Sentiment 0.0
Fundamentals (TTM)As of 2026-07-20
Fundamentals (TTM)
As of 2026-07-20
Market Cap
$2.32B
Beta
2.27
Shares Out
186.03M
P/E (TTM) · Derived
-50.6
P/S (TTM)
-
P/FCF (TTM) · Derived
-55.94
Rev YoY
-100.0%
EPS YoY
-26.4%
Gross Margin
+44.3%
Op Margin
-
Net Debt
-$70.89M
Current Ratio
17.22
As of 2026-07-21 • Updated nightlySource: Internal modelMethodology